Acute Coronary Syndrome and Acupressure

Launched by ABANT IZZET BAYSAL UNIVERSITY · Mar 2, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how acupressure, a technique that involves applying pressure to specific points on the body, can help individuals with Acute Coronary Syndrome (ACS). The researchers want to see if acupressure can reduce anxiety and improve other important health measures, like blood pressure, heart rate, respiratory rate, pain levels, and cortisol levels (a stress hormone).

To participate in this study, you need to be at least 18 years old, speak Turkish, and be diagnosed with ACS for the first time. You should not have any serious health conditions like severe heart problems or mental health issues. If you join the study, you will receive acupressure treatment and the team will monitor your health closely. This trial is currently looking for volunteers, so if you meet the criteria and are interested in helping researchers learn more about this alternative treatment, you may want to consider participating.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Volunteer to participate in the study,
• • Those aged 18 and over
• • Able to speak Turkish
• • Diagnosed with ACS for the first time
• • Cardiopulmonary resuscitation not applied
• • No orientation problems (those who score 15 on the Glasgow Coma Scale)
• • Not diagnosed with psychiatric disease
• • No amputation, fistula, lymphedema, neuropathy or hemiplegia in any of the Upper Extremities
• • Those who underwent femoral intervention for CAG procedure
• • Those who have not used any integrative practices based on pressure and stimulation such as acupressure, acupuncture and reflexology in the last month.
• * Vital signs (28) are within normal range:
• • Blood pressure: 90/60-120/80 mmHg Heart rate: 60-100 min Respiratory rate: 12-18 min
• Exclusion Criteria:
• • Those with arrhythmia (AF, VT etc.)
• • Patients who have previously undergone Coronary Angiography
• • Diagnosed with myocarditis, pericarditis
• • Those who do not take any speed-breaking drugs (beloc, arlec, etc.).
• • Patients who underwent radial intervention for CAG procedure